Patents by Inventor Harumi Arisaka

Harumi Arisaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9822110
    Abstract: Provided is a sulfonamide derivative represented by the following general formula (1) and having an ?4 integrin inhibitory effect with high selectivity with a low effect on ?4?1 and a high effect on ?4?7, or a pharmaceutically acceptable salt thereof (in the general formula (1), A, B, D, E, R41, and a to h are as described in the description).
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: November 21, 2017
    Assignee: EA Pharma Co., Ltd.
    Inventors: Hirokazu Ueno, Takashi Yamamoto, Tomoko Miyazawa, Kenji Shinkai, Harumi Arisaka, Toshiyuki Takanohashi
  • Publication number: 20160244451
    Abstract: Provided is a sulfonamide derivative represented by the following general formula (1) and having an ?4 integrin inhibitory effect with high selectivity with a low effect on ?4?1 and a high effect on ?4?7, or a pharmaceutically acceptable salt thereof (in the general formula (1), A, B, D, E, R41, and a to h are as described in the description).
    Type: Application
    Filed: April 29, 2016
    Publication date: August 25, 2016
    Applicant: Ajinomoto Co., Inc.
    Inventors: Hirokazu UENO, Takashi YAMAMOTO, Tomoko MIYAZAWA, Kenji SHINKAI, Harumi ARISAKA, Toshiyuki TAKANOHASHI
  • Patent number: 7767236
    Abstract: Plant seed extract compositions obtained by washing a defatted plant seed with water, and extracting the resulting washed seed product with an organic solvent and safflower seed extract compositions wherein the weight ratio of the total content of (a) p-coumaroylserotonin, feruloylserotonin, p-coumaroylserotonin glycoside, and feruloylserotonin glycoside to (b) 2-hydroxyarctiin is 1:0.01 to 0.2, are effective for reducing the risk of developing atherosclerosis and diseases caused by atherosclerosis and also exhibit a reduced tendency to cause diarrhea.
    Type: Grant
    Filed: April 10, 2006
    Date of Patent: August 3, 2010
    Assignee: Ajinomoto Co., Inc.
    Inventors: Naoto Koyama, Tetsuya Seki, Harumi Arisaka, Koichi Ishii
  • Publication number: 20060257540
    Abstract: Plant seed extract compositions obtained by washing a defatted plant seed with water, and extracting the resulting washed seed product with an organic solvent and safflower seed extract compositions wherein the weight ratio of the total content of (a) p-coumaroylserotonin, feruloylserotonin, p-coumaroylserotonin glycoside, and feruloylserotonin glycoside to (b) 2-hydroxyarctiin is 1:0.01 to 0.2, are effective for reducing the risk of developing atherosclerosis and diseases caused by atherosclerosis and also exhibit a reduced tendency to cause diarrhea.
    Type: Application
    Filed: April 10, 2006
    Publication date: November 16, 2006
    Applicant: Ajinomoto Co., Inc.
    Inventors: Naoto Koyama, Tetsuya Seki, Harumi Arisaka, Koichi Ishii
  • Publication number: 20040063701
    Abstract: The present invention relates to a novel serotonin antagonist and an anti-platelet agent, more particularly, a serotonin antagonist and an anti-platelet agent which potently and specifically inhibit the serotonin 2 receptor with low adverse side effect.
    Type: Application
    Filed: September 10, 2003
    Publication date: April 1, 2004
    Applicant: AJINOMOTO CO., INC
    Inventors: Shingo Makino, Harumi Arisaka, Hiroshi Yamamoto, Masataka Shoji, Ryota Yoshimoto
  • Publication number: 20020147195
    Abstract: The present invention relates to a novel serotonin antagonist and an anti-platelet agent, more particularly, a serotonin antagonist and an anti-platelet agent which potently and specifically inhibit the serotonin 2 receptor with low adverse side effect.
    Type: Application
    Filed: March 21, 2002
    Publication date: October 10, 2002
    Applicant: AJINOMOTO CO., INC.
    Inventors: Shingo Makino, Harumi Arisaka, Hiroshi Yamamoto, Masataka Shoji, Ryota Yoshimoto
  • Publication number: 20020019533
    Abstract: The present invention relates to a novel serotonin antagonist and an anti-platelet agent, more particularly, a serotonin antagonist and an anti-platelet agent which potently and specifically inhibit the serotonin 2 receptor with low adverse side effect.
    Type: Application
    Filed: February 8, 1999
    Publication date: February 14, 2002
    Inventors: SHINGO MAKINO, HARUMI ARISAKA, HIROSHI YAMAMOTO, MASATAKA SHOJI, RYOTA YOSHIMOTO
  • Patent number: 5932593
    Abstract: The present invention also relates to a method of using these novel materials, and other materials, to treat or prevent a disease caused by serotonin or a method of treating or preventing platelet aggregation. The compounds used are piperidine derivatives having the formula (I): ##STR1## wherein the various substituents are defined below.
    Type: Grant
    Filed: August 25, 1997
    Date of Patent: August 3, 1999
    Assignee: Ajinomoto Co., Ltd.
    Inventors: Shingo Makino, Harumi Arisaka, Hiroshi Yamamoto, Masataka Shoji, Ryota Yoshimoto